- Q1 1 %50.0
- Q2 1 %50.0
- Q3 0 %0.0
- Q4 0 %0.0
Academician
ERKİNGÜL BİRDAY
Profesör
İstanbul Medipol Üniversitesi Tıp Fakültesi Dahili Tıp Bilimleri Bölümü
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Nöroloji
Citation impact
OpenAlex YÖKSİS articles matched in OpenAlex: 3 + YÖKSİS · co-author record: 5- i10-index
- 1
- Total citations
- 55 Top 78% in Türkiye
- Per article
- 6.9
- FWCI
- 0.78 1.00 = world average
- World top 1%
- 0
- World top 10%
- 0
Most cited articles
h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 5 articles (50 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.
Field ranking
YÖKSİS ?-
Main field Sağlık Bilimleri Temel AlanıPoints rank #23,276/ 39,749 top 58.6% At university #388/ 750Score 6.8 journal 6.8 · OA add 0
- Article rank16,448/39,749
- Scopus rank27,360/39,749
- WoS rank27,139/39,749
- YÖKSİS27
- Scopus2
- WoS2
-
Side field NörolojiPoints rank #410/ 624 top 65.7% At university #5/ 12Score 6.8 journal 6.8 · OA add 0
- Article rank314/624
- Scopus rank453/624
- WoS rank455/624
- YÖKSİS27
- Scopus2
- WoS2
Collaboration network
From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.
- Co-authors
- 77
- With an akaturk profile
- 4
- Turkish institutions
- 1
- Co-authored works
- %93
Academic co-authors 4
- ALİ BEHRAM SALAR Doktor Öğretim Üyesi · İstanbul Medipol Üniversitesi same university 1
- BAYRAM UFUK ŞAKUL Profesör · İstanbul Medipol Üniversitesi same university 1
- GAMZE ANSEN Doktor Öğretim Üyesi · Üsküdar Üniversitesi 1
- LÜTFÜ HANOĞLU Profesör · İstanbul Medipol Üniversitesi same university 1
National collaboration 1 institutions
Within own university1 joint works · İstanbul Medipol Üniversitesi
- Üsküdar Üniversitesi 1 works · 1 academics
Other co-authors (incl. international) 73
Erdem Tüzün 16Murat Kürtüncü 16Gülşen Akman Demir 12Mefkure Eraksoy 11Arzu Çoban 6Aslı Kiyat Atamer 5Canan Ulusoy 5Recai Türkoğlu 5Esme Ekizoğlu 4B Baykan 3Burçak Vural 3Elif Uğurel 3Melike Mutlu 3Münevver Pehlivan 3Sema İçöz 3A Gül 2A O Güre 2Angela Vincent 2Belgin Petek Balcı 2Elçin Şehitoğlu 2Filiz Çavuş 2H Haytural 2Mark Woodhall 2Patrick Waters 2Ömer Birişik 2İ Güngör 2A AydoseliA C BozkayaA GökyiğitA KarabulutA N İzgiA ÖzgeABDULKADİR ERMİŞAdalet ArıkanoğluB GüveliC GürsesC I KüçükaliC ZisimopoulouD KaradenizE Akosy Güzelller
Show all (73)
E Kocasoy OrhanE N VanlıFeza DeymeerG BenbirG İbrahimovaGüher Saruhan DireskeneliH ŞirinI Baral KulaksızoğluJ TzartosL BulutM B BasloM ErtaşM GirişM KüçükerdenM M AtmacaMaria Isabel LeiteMefkure ErakosyN BebekN YalçınkayaNilüfer YeşilotPiraye OflazerS AlimS TuranS TzartosS YumerhodzhaS YılmazerSibel YeniturU ÖzbekV ÖztürkYeşim ParmanZ Karaaslanİlknur Tugal TutkunŞ Atakan
Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.
Index quartiles
?- Q1 0 %0.0
- Q2 2 %100.0
- Q3 0 %0.0
- Q4 0 %0.0
Other counts
Scopus (SJR)
- YÖKSİS rows 3
WoS (JCR)
- YÖKSİS rows 3
Projects
Research and development projects recorded in YÖKSİS.
Records
-
— EFC 6260 Faz III Sanofi Aventis TOPİC Multipl skleroz düşündüren ilk klinik epizodunu geçiren hastalarda plasebo karşısında teriflunomid günde bir kez 7mg ve günde bir kez 14mg dozunda iki yıl süreli tedavinin etkinliğini ve güvenliğini değerlendiren uluslararası çok merkezli randomize çift kör plasebo kontrollü paralel grup çalışması
-
— FTY 720 D2399 Faz III A single arm open label multi center study evaluating the long term safety tolerability an efficacy of 0 5 mg Fingolimod FTY720 administered orally once daily in patients with multiple sclerosis
-
— FTY 720 2301E1 An extension of the A 24 month double blind randomized multicenter placebo controlled parallel group study comparing efficacy and safety of FTY720 1 25 mg an 0 5 mg administered orally once daily versus placebo in patients with relapsing remitting multiple sclerosis
-
— FTY 720 D2301 Faz III A 24 month double blind randomized multicenter placebo controlled parallel group study comparing efficacy and safety of FTY720 1 25 mg an 0 5 mg administered orally once daily versus placebo in patients with relapsing remitting multiple sclerosis
-
— Migren Atak Tedavisinde Etodolak Etkinliğinin Değerlendirilmesi Çapraz Randomize Çift Kör Karşılaştırılmalı faz IV Çalışma